The Economic Burden of Acute Myeloid Leukemia in Iran
Background: Cancer imposes a significant economic burden on the health system and society. Acute myeloid leukemia (AML) is the third deadliest leukemia and is one of the leading health problems worldwide. The present study aimed to estimate the economic burden of AML in Iran for 2020. Methods: I...
Main Authors: | Vahid Alipour, Soroush Rad, Shahin Nargesi, Fateme Mezginejad, Reza Jahangiri, Zeinab Dolatshahi, Seyed Asadollah Mousavi, Zahra Moshkani |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-11-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/24990 |
Similar Items
-
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01) -
Care Burden in Parents of Children with Leukemia: A Cross-Sectional Study in the West of Iran
by: Mohammad Esmail Motlagh, et al.
Published: (2019-06-01) -
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors
by: Alejandro Zulbaran‐Rojas, et al.
Published: (2018-11-01) -
Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia
by: Ladan Nekoohesh, et al.
Published: (2020-01-01) -
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
by: Carolina Alarcón-Payer, et al.
Published: (2022-09-01)